Trade Summary

1 week ago, WALTERS GROUP, serving as 10% owner Owner at Zentalis Pharmaceuticals, Inc. (ZNTL), purchased 4,335,000 shares at $3.50 per share, for a total transaction value of $15,172,500.00. Following this transaction, WALTERS GROUP now holds 17,844,973 shares of ZNTL.

This purchase represents a 32.09% increase in WALTERS GROUP's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, August 14, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, August 19, 2026 at 6:11 PM ET, 5 days after the trade was made.

Zentalis Pharmaceuticals, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.